Related references
Note: Only part of the references are listed.Prediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model
Kun Hao et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Rhein Induces a Necrosis-Apoptosis Switch in Pancreatic Acinar Cells
Xianlin Zhao et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Design, synthesis and evaluation of novel tacrine rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease
Su-Yi Li et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
Shinji Kume et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Diabetic nephropathy and inflammation
Montserrat B. Duran-Salgado et al.
WORLD JOURNAL OF DIABETES (2014)
Rhein Inhibits the Expression of Vascular Cell Adhesion Molecule 1 in Human Umbilical Vein Endothelial Cells with or without Lipopolysaccharide Stimulation
Gang Hu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2013)
Rhein Protects Pancreatic β-Cells From Dynamin-Related Protein-1-Mediated Mitochondrial Fission and Cell Apoptosis Under Hyperglycemia
Jing Liu et al.
DIABETES (2013)
Rhein Inhibits Integrin-Linked Kinase Expression and Regulates Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio in High Glucose-Induced Epithelial-Mesenchymal Transition of Renal Tubular Cell
Linlin Peng et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
ER Stress, P66shc, and P-Akt/Akt Mediate Adjuvant-Induced Inflammation, Which Is Blunted by Argirein, a Supermolecule and Rhein in Rats
Xiao-Dong Cong et al.
INFLAMMATION (2012)
Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice
H. Du et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2012)
MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients
Rizk El-Baz et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2012)
Protective effect of rhein against oxidative stress-related endothelial cell injury
Xian-Feng Zhong et al.
MOLECULAR MEDICINE REPORTS (2012)
Sugar, Sex, and TGF-β in Diabetic Nephropathy
Maggie K. Diamond-Stanic et al.
SEMINARS IN NEPHROLOGY (2012)
Rhein Reduces Fat Weight in db/db Mouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγ Signaling
Yu Zhang et al.
PPAR RESEARCH (2012)
Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice
Xiaoyan Sheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue
C. Hu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Rhein Improves Renal Lesion and Ameliorates Dyslipidemia in db/db Mice with Diabetic Nephropathy
Qing Gao et al.
PLANTA MEDICA (2010)
Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production
Sook-Kyoung Heo et al.
VASCULAR PHARMACOLOGY (2010)
Anti-angiogenic effects of rhubarb and its anthraquinone derivatives
Zhi-Heng He et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Microvascular Complications of Diabetes Mellitus: Renal Protection Accompanies Cardiovascular Protection
W. Virgil Brown
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway
J-M Zheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Oxidative stress as a major culprit in kidney disease in diabetes
Josephine M. Forbes et al.
DIABETES (2008)
Unraveling the role of connective tissue growth factor in diabetic nephropathy
K. M. Schmidt-Ott
KIDNEY INTERNATIONAL (2008)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Involvement of glomerular SREBP-1c in diabetic nephropathy
Naomi Ishigaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice
Z. H. Jia et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
Genome-wide scans for diabetic nephropathy and albuntinuria in multiethnic populations - The family investigation of nephropathy and diabetes (FIND)
Sudha K. Iyengar et al.
DIABETES (2007)
Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy
Tetyana L. Vasylyeva et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Pharmacokinetic of rhein in healthy male volunteers following oral and retention enema administration of rhubarb extract: A single dose study
W Zhu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2005)
Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes
Y Wang et al.
DIABETES CARE (2003)
Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: A potential role in diabetic nephropathy
D Senthil et al.
KIDNEY INTERNATIONAL (2003)
Rhein inhibits interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-κB and AP-1 in chondrocytes cultured in hypoxia:: A potential mechanism for its disease-modifying effect in osteoarthritis
G Martin et al.
INFLAMMATION (2003)
Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients
M Eto et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Share Paper
